|
Increasing appropriate use of tPA will:
|
|
Save lives
|
185 (43.1)
|
155 (36.1)
|
89 (20.7)
|
|
Not result in unnecessary adverse events
|
267 (62.3)
|
102 (23.8)
|
60 (14.0)
|
|
Improve the odds of independent survival for stroke patients
|
109 (25.4)
|
150 (35.0)
|
170 (39.6)
|
|
The evidence underpinning tPA use:*
|
|
Is strong when administered within 4.5 h of stroke onset
|
226 (54.4)
|
119 (28.7)
|
70 (16.8)
|
|
Indicates that the benefits outweigh the risks if the treatment protocol is followed
|
134 (32.3)
|
107 (25.8)
|
173 (42.0)
|
|
Is strong enough to warrant the use of this treatment
|
141 (34.0)
|
119 (28.7)
|
155 (37.4)
|
